← Back to Patent Explorer
US4318912A Expired / Lapsed US ⏱️ 0.0 years remaining

6-(1-Hydroxyethyl)-3-substituted-1-azabicyclo(3.2.0)-hept-2-en-7-one-2-carboxylic acid

Assignee: Merck and Co Inc
•
Filing: 1980-06-18
•
Granted: 1982-03-09
•
Expires: 2000-06-18
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Disclosed are 6-(1'-hydroxyethyl)-3-substituted-1-azabicyclo[3.2.0]hept-2-en-7-one-2 -carboxylic acids(I): <IMAGE> I wherein X is halo, oxygen (the 2-3 bond is saturated and the species I exists as the carboxylate salt or ester), or -OR wherein R is, inter alia, acyl, alkyl or aralkyl. Such compounds and their O- and carboxyl derivatives are useful as antibiotics. Also disclosed are processes for the preparation of such compounds, pharmaceutical compositions comprising such compounds and methods of treatment comprising administering such compounds and compositions when an antibiotic effect is indicated.

Inventors

  • 👤 Burton G. Christensen
  • 👤 Ronald W. Ratcliffe

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-05 09:53
CPC Classifications
C; C07; C07D; C07D477/00; C07D477/10; C07D477/12; C07D477/16; C07D205/00; C07D205/02; C07D205/06; C07D205/08; C07F; C07F7/00; C07F7/02; C07F7/08; C07F7/10; C07F9/00; C07F9/02; C07F9/547; C07F9/6561; C07F9/65611

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 111 words
A compound having the structural formula: ##STR98## and the pharmaceutically acceptable salt derivatives thereof wherein: R 4 is hydrogen; and X is chloro, bromo, oxygen (when X is oxygen, the 2-3 bond is saturated), or --OR wherein R is selected from the group consisting of substituted and unsubstituted alkyl, having 1-6 carbon atoms, cycloalkyl and cycloalkylalkyl wherein the ring moiety comprises 3-6 carbon atoms and the alkyl comprises 1-4 carbon atoms, aralkyl having from 7-16 carbon atoms and acyl wherein acyl is selected from the group consisting of ##STR99## wherein the substituent or substituents on the radical R are selected from: amino or monoalkylamino wherein the alkyl has 1-6 carbon atoms.
Claim 2
Dependent Claim 111 words
A compound having the structural formula: ##STR98## and the pharmaceutically acceptable salt derivatives thereof wherein: R 4 is hydrogen; and X is chloro, bromo, oxygen (when X is oxygen, the 2-3 bond is saturated), or --OR wherein R is selected from the group consisting of substituted and unsubstituted alkyl, having 1-6 carbon atoms, cycloalkyl and cycloalkylalkyl wherein the ring moiety comprises 3-6 carbon atoms and the alkyl comprises 1-4 carbon atoms, aralkyl having from 7-16 carbon atoms and acyl wherein acyl is selected from the group consisting of ##STR99## wherein the substituent or substituents on the radical R are selected from: amino or monoalkylamino wherein the alkyl has 1-6 carbon atoms.
Claim 3
Dependent Claim 16 words
A compound according to claim 1 wherein R is selected from the group consisting of: ##STR100##
Claim 4
Dependent Claim 16 words
A compound having the structure: ##STR101## wherein R is hydrogen or a pharmaceutically acceptable salt cation.
Claim 5
Dependent Claim 16 words
A compound having the structure: ##STR101## wherein R is hydrogen or a pharmaceutically acceptable salt cation.
Claim 6
Dependent Claim 22 words
An antibiotic pharmaceutical composition comprising a therapeutically effective amount of a compound according to claim 1 and a inert pharmaceutical carrier therefor.

References Cited (Backward Citations)

US4235920A Cited
US4235917A Cited
US4232036A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1985-03-08 1985-09-07 1986-03-09 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1989-03-08 1989-09-07 1990-03-09 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1993-03-08 1993-09-07 1994-03-09 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag